Professor Bruce Morland
Professor of Paediatric Oncology
Professor Morland manages children with non-CNS (Central Nervous System) solid tumours. He is an international expert in the treatment of liver and bone tumours. He has extensive experience in the development of novel new therapies for childhood cancer and the conduct of early phase clinical trials. Dr Morland has been involved in the organisation of national cancer services for children for many years and has previously been Chairman of the Children’s Cancer and Leukaemia Group.
Professor Morland is the Director of Research & Development and Deputy Chief Medical Officer at the Hospital. He is involved in strategic planning of research activity for the whole Hospital working closely with the Universities of Birmingham and Aston and other hospitals in the area.
Professor Morland’s own research interests are in drug discovery and early phase clinical trials and he is Vice President of the Innovative Therapies for Childhood Cancer (ITCC) European network. He is also currently the Chairman of the International Liver Cancer Group (SIOPEL) and is leading the development of a new trial for children with liver cancer in collaboration with centres in Europe, USA and Japan.
0121 333 8233
- Liver and bone tumours
- Research - drug discovery
- Early phase clinical trials